StrategyLand Research Center
Screener
Market IntelligenceInsightsFeasibility Studies
Stock MarketCoding for Beginners
PricingAboutContact
Log InGet Started

Market Intelligence

Research notes, macro analysis and market commentary from the Strategyland research team.

SpaceX: Some Important Dates
IPO & Equity
Aug 2026

SpaceX: Some Important Dates

Up to $108 billion in shares eligible to trade as lock-up tranches begin releasing post-IPO

Strategyland Research Team4 min read
Moderna and Merck - mRNA based cancer vaccine
Pharma

Moderna and Merck - mRNA based cancer vaccine

Aug 20265 min
SpaceX: Total Shares unlocked today: 911.5 million
IPO & Equity

SpaceX: Total Shares unlocked today: 911.5 million

Aug 20262 min
AstraZeneca merger talk with Bristol-Myers Squibb - $400 billion
M&A

AstraZeneca merger talk with Bristol-Myers Squibb - $400 billion

Aug 20263 min
Unitree IPO: The Rise of Humanoid Robotics
IPO & Equity

Unitree IPO: The Rise of Humanoid Robotics

May 20264 min
WTI Crude Oil: Volatility Surge & Hedging Costs
Commodities

WTI Crude Oil: Volatility Surge & Hedging Costs

May 202610 min
AI CAPEX: $3.5 Trillion Hyperscaler Spending
Technology

AI CAPEX: $3.5 Trillion Hyperscaler Spending

Jan 20269 min
UK Interest Rate Cut: Growth Forecast Halved
Macro & Rates

UK Interest Rate Cut: Growth Forecast Halved

Feb 20263 min
HQLA: Gold's Regulatory Classification Debate
Regulation

HQLA: Gold's Regulatory Classification Debate

Sep 20254 min

Stay Informed

Get our latest research notes and market analysis delivered to you.

Subscribe

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.